Navigation Links
Infinata's BioPharm Insight Journalist Awarded Fellowship by Association of Health Care Journalists
Date:2/20/2013

Norwood, MA (PRWEB) February 20, 2013

Infinata’s BioPharm Insight™ announced that Senior Reporter Christine Livoti has been awarded an Association of Health Care Journalists (AHCJ) fellowship. The fellowship allows for Ms. Livoti to attend AHCJ's annual Health Journalism conference taking place next month.

BioPharm Insight offers the global biopharmaceutical community a unique combination of business intelligence, independent investigative journalism, market analytics, and key industry contacts.

The 1300-member AHCJ is an independent, nonprofit organization dedicated to advancing public understanding of health care issues. Its mission is to improve the quality, accuracy and visibility of health care reporting, writing and editing. The organization received a record number of fellowships applications this year.

Ms. Livoti is a member of BioPharm Insight's global team of investigative journalists who provide subscribers with a daily stream of proprietary intelligence predicting market-moving events 6-12 months in advance. Free of any conflicts of interest, the independent editorial team breaks daily news on the most important topics in healthcare.

Ms. Livoti is adept at biopharmaceutical industry and business expertise. Prior to BioPharm Insight she worked with NABsys, the Slater Technology Fund and Landmark Ventures. She is Brown University graduate with Bachelor and Master degrees in Biology. Ms. Livoti has published her tissue engineering research. Her coverage areas include diabetes, HIV/HCV, melanoma, sequencing technology, and diagnostics.

Learn how BioPharm Insight can help you find new business opportunities by starting a free trial today.

About BioPharm Insight
BioPharm Insight is the definitive guide to the global biopharma community. BioPharm Insight provides subscribers with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit http://www.biopharminsight.com. Follow BioPharm Insight on LinkedIn and Twitter.

About Infinata, Inc.
Infinata provides personalized technology solutions to turn information into insight. Services include a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit http://www.infinata.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10445739.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Infinata's BioPharm Clinical™ to Present Session on Improving Investigator Selection at CHI’s Summit for Clinical Operations (SCOPE) on February 6 in Miami, FL
2. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
3. PDL BioPharma Announces Adjusted Conversion Rates for Its Convertible Notes
4. CeNeRx BioPharma Completes $4.85 Million Financing
5. PDL BioPharma Completes Regular Quarterly Dividend Payment
6. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
7. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
8. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
9. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
10. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
11. Galien Foundation Announces 2012 Awards Program For Best Biopharmaceutical Products and Best Medical Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2020)... ... 2020 , ... The Conference Forum is pleased to announce ... the unique role of the Chief Medical Officer in the biotech industry. The ... practices and career development of CMOs and Heads of R&D from different therapeutic ...
(Date:5/21/2020)... (PRWEB) , ... May 21, 2020 , ... ... of clinical trials will cause long-term harm , Contrary to conventional wisdom that ... Institute study finds many companies will emerge from the pandemic commercially weaker, ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... working cell banks and hMSC bioprocess systems, today announced the launch of ... hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed with hMSC-EV ...
(Date:5/14/2020)... ... May 12, 2020 , ... ... as the new distribution partner for all personal care ingredients in Russia and ... and DuPont preservative portfolio for personal care. , The GENENCARE®OSMS product ...
Breaking Biology Technology:
(Date:6/5/2020)... ... June 04, 2020 , ... Murrieta Genomics has announced that its ... simplified sample preparation for Next Generation Genomic Sequencing (NGS) . This is the ... complexity of sample preparation. , “I have been at the bench for over 20 ...
(Date:6/2/2020)... MILWAUKEE (PRWEB) , ... June ... ... International, the world’s leading barcode and RFID labeling software developer and solutions ... TEKLYNX CENTRAL , improved labeling accuracy and compliance by 100%, resulting ...
(Date:5/28/2020)... ... May 27, 2020 , ... Today bioinformatics leader ... solution that uniquely combines lab testing insights and hc1’s exclusive Local Risk Index ... health and safety of employees returning to the workplace. , “Some of the ...
Breaking Biology News(10 mins):